Debevec T, Millet GP, Pialoux V
M.ApodacaM
In studies in dogs with liver disease, supplementation with 12.7515 mg silybin (a flavonoid from milk thistle) per 10 kg body weight per day for 2860 days reduced biomarkers of liver damage and improved liver function tests
Key findings Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Below is a Q&A with study senior author Dr
Chng cng gip ci thin sc khe tng th, tr hon s khi pht ca cc bnh mn tnh, tng cng h min dch v iu tr bnh scorbut Thm vo , Glutathione cn c th kt hp vi vitamin D
If you are taking any prescription medications, especially those for liver function or chemotherapy, it is essential to consult your healthcare provider before starting
